Nurix Therapeutics Inc. Revenue 2019–2025
Nurix Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Nurix Therapeutics Inc. revenue for the quarter ending February 28, 2026 was 6.3 M, a 66.12% decrease year-over-year.
- Nurix Therapeutics Inc. revenue for the twelve months ending February 28, 2026 was 76.7 M, a 28.33% increase year-over-year.
- Nurix Therapeutics Inc. annual revenue for 2025 was 84.0 M, a 53.95% increase from 2024.
- Nurix Therapeutics Inc. annual revenue for 2024 was 54.5 M, a 29.15% decrease from 2023.
- Nurix Therapeutics Inc. annual revenue for 2023 was 77.0 M, a 99.31% increase from 2022.
- Nurix Therapeutics Inc. annual revenue for 2022 was 38.6 M.
Nurix Therapeutics Inc. (NRIX) — Frequently Asked Questions
Nurix Therapeutics Inc. (NRIX) is a publicly traded US company. It has a market capitalization of $1.44B. In fiscal 2025 it reported revenue of $84M and net income of -$264M. Explore NRIX's stock price, financial statements, earnings history, margins and key ratios below.
What is Nurix Therapeutics Inc.'s market cap?
Nurix Therapeutics Inc. (NRIX) has a market capitalization of $1.44B.
What is the NRIX stock price?
NRIX trades at $16.63 (+8.69% on the day).
How much revenue does Nurix Therapeutics Inc. make?
Nurix Therapeutics Inc. reported revenue of $84M in fiscal 2025.
Is NRIX profitable?
In fiscal 2025, Nurix Therapeutics Inc. reported net income of -$264M.